We are live on ! Find out more
BMRN icon

BioMarin Pharmaceuticals
BMRN

547 hedge funds and large institutions have $18B invested in BioMarin Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 85 funds opening new positions, 178 increasing their positions, 207 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 85 | Existing positions closed: 50

36% more call options, than puts

Call options by funds: $193M | Put options by funds: $141M

12% more capital invested

Capital invested by funds: $16.1B → $18B (+$1.96B)

5% more funds holding

Funds holding: 519 → 547 (+28)

2.79% more ownership

Funds ownership: 96.45% → 99.24% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 14 → 14 (0)

14% less repeat investments, than reductions

Existing positions increased: 178 | Existing positions reduced: 207

Holders
547
Holders Change
+28
Holders Change %
+5.39%
% of All Funds
7.97%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
85
Increased
178
Reduced
207
Closed
50
Calls
$193M
Puts
$141M
Net Calls
+$51.4M
Net Calls Change
-$924K

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$421M
2
EIM
Elliott Investment Management
Florida
+$265M
3
Deutsche Bank
Deutsche Bank
Germany
+$177M
4
Morgan Stanley
Morgan Stanley
New York
+$99M
5
Millennium Management
Millennium Management
New York
+$80M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$337M
2
Nomura Holdings
Nomura Holdings
Japan
-$62.6M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$56.1M
4
Pictet Asset Management
Pictet Asset Management
Switzerland
-$44.7M
5
PHS
PFM Health Sciences
California
-$44.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
101
State Board of Administration of Florida Retirement System
Florida
$20.6M -$714K -8,068 -4%
MCM
102
Moore Capital Management
New York
$20.2M +$1.31M +14,800 +8%
IG
103
ING Group
Netherlands
$20.2M +$18.6M +210,000 New
Wells Fargo
104
Wells Fargo
California
$20.2M -$3.47M -39,267 -16%
SPS
105
Susquehanna Portfolio Strategies
Pennsylvania
$19.5M +$17.9M +202,685 New
ITP
106
Iron Triangle Partners
Connecticut
$19.3M +$17.7M +200,000 New
CGI
107
Comgest Global Investors
France
$19.2M +$1.97M +22,313 +13%
D.E. Shaw & Co
108
D.E. Shaw & Co
New York
$18.6M -$29.3M -331,687 -63%
TD Asset Management
109
TD Asset Management
Ontario, Canada
$18.4M +$1.58M +17,858 +10%
BA
110
Bridgewater Associates
Connecticut
$18.4M +$2.62M +29,576 +18%
Citigroup
111
Citigroup
New York
$18.4M -$1.62M -18,316 -9%
Rockefeller Capital Management
112
Rockefeller Capital Management
New York
$18.4M +$952K +10,760 +6%
Mitsubishi UFJ Trust & Banking
113
Mitsubishi UFJ Trust & Banking
Japan
$18M +$708K +7,999 +4%
FLAM
114
First Light Asset Management
Minnesota
$17.9M +$11M +123,823 +201%
Jane Street
115
Jane Street
New York
$17.6M +$5.12M +57,878 +46%
SSA
116
Schonfeld Strategic Advisors
New York
$16.5M +$6.74M +76,159 +80%
TIM
117
Thornburg Investment Management
New Mexico
$16.5M -$9.31M -105,276 -38%
HJGA
118
Hardman Johnston Global Advisors
Connecticut
$16.4M -$139K -1,570 -0.9%
SEI Investments
119
SEI Investments
Pennsylvania
$16.3M +$7.61K +86 +0.1%
TRSOTSOK
120
Teachers Retirement System of the State of Kentucky
Kentucky
$15.8M -$1.23M -13,897 -8%
Royal Bank of Canada
121
Royal Bank of Canada
Ontario, Canada
$15.6M +$215K +2,430 +2%
Ensign Peak Advisors
122
Ensign Peak Advisors
Utah
$15.2M +$3.37M +38,095 +32%
Envestnet Asset Management
123
Envestnet Asset Management
Illinois
$15.1M +$2.71M +30,584 +24%
DIG
124
DeepCurrents Investment Group
New York
$14.8M +$446K +5,047 +3%
RSCM
125
Rock Springs Capital Management
Maryland
$14.4M -$10.2M -115,668 -44%
3 4
5
6 7

BMRN Hedge Fund Activity: Q4 2023 in Review

547 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioMarin Pharmaceuticals (BMRN) for Q4 2023, worth a combined $18B — up 12% from $16.1B a quarter earlier.

Buyers outnumbered sellers: 85 funds opened new BMRN positions and 50 closed out — a net gain of 35 holders — while 178 added to existing stakes and 207 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $421M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $337M sold.

  • 547 institutional investors held BioMarin Pharmaceuticals (BMRN) as of Q4 2023, up from 519 in Q3 2023.
  • Funds reported $18B of BioMarin Pharmaceuticals stock for Q4 2023, up 12% quarter-over-quarter.
  • 85 funds opened new BioMarin Pharmaceuticals positions in Q4 2023 and 50 closed out, a net change of +35 holders.
  • The largest BioMarin Pharmaceuticals buyer in Q4 2023 was Capital Research Global Investors, an estimated $421M added.
  • The largest BioMarin Pharmaceuticals seller in Q4 2023 was Baker Bros. Advisors, an estimated $337M sold.

Based on aggregated 13F filings for Q4 2023.